Brief: Atara Biotherapeutics Q4 EPS USD -0.56
28/03/2024 12:30
Mar 28 (Reuters) - Atara Biotherapeutics Q4 net income USD -60.45 million. * Q4 operating income USD -59.962 million * Q4 revenue USD 4.189 million
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing